The pill version of Wegovy seems to work just as well as the injectable form, but there are some key differences between the ...

Americans seeking to lose weight now have a new option – taking Wegovy as a daily pill, rather than a weekly injection.

In December 2025, the U.S. Food and Drug Administration gave the green light to a pill version of the blockbuster weight loss ...

Add Yahoo as a preferred source to see more of our stories on Google. The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance. Drugmaker Novo Nordisk ...

The Danish drugmaker said adjusted sales should decline between 5% and 13% at constant exchange rates in 2026.

Add Yahoo as a preferred source to see more of our stories on Google. In the last week of December, while most of the U.S. was still in holiday mode, Novo Nordisk’s plant in North Carolina was ...

In December, Novo Nordisk announced that the Food and Drug Administration had approved its once-daily Wegovy pill, the first oral GLP-1 medicine for obesity in the United States. It remains the only ...

By Sriparna Roy Jan 23 (Reuters) - Novo Nordisk's Wegovy pill was prescribed more than 18,000 times in the U.S. in the first ...

President Donald Trump announced a new agreement with Eli Lilly and Novo Nordisk to expand coverage and lower prices for popular obesity drugs Zepbound and Wegovy, part of the GLP-1 class of ...

NEW YORK — A new pill form of the weight-loss drug Wegovy is now available to people in the United States, giving adults a daily tablet option instead of a weekly injection, health officials and the ...

PLAINSBORO, N.J., Aug. 15, 2025 /PRNewswire/ -- Novo Nordisk (NVO) today announced that the US Food and Drug Administration (FDA) has approved a new indication for Wegovy ® (semaglutide) injection 2.4 ...

Novo Nordisk is chopping prices again for Wegovy, but doctors say the expense will remain challenging for patients without insurance. The drugmaker said Monday that it has started selling higher doses ...